Computational Approaches for Decoding Select Odorant-Olfactory Receptor Interactions Using Mini-Virtual Screening
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity. -
Produktinformation
Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic SANTA CRUZ BIOTECHNOLOGY, INC. OR2M5 siRNA (h): sc-88564 BACKGROUND STORAGE AND RESUSPENSION Olfactory receptors are G protein-coupled receptor proteins that localize to the Store lyophilized siRNA duplex at -20° C with desiccant. Stable for at least cilia of olfactory sensory neurons where they display affinity for and bind to one year from the date of shipment. Once resuspended, store at -20° C, a variety of odor molecules. The genes encoding olfactory receptors comprise avoid contact with RNAses and repeated freeze thaw cycles. the largest family in the human genome. The binding of olfactory receptor Resuspend lyophilized siRNA duplex in 330 µl of the RNAse-free water proteins to odor molecules triggers a signal transduction cascade that leads provided. Resuspension of the siRNA duplex in 330 µl of RNAse-free water to the production of cAMP via an olfactory-enriched adenylate cyclase. This makes a 10 µM solution in a 10 µM Tris-HCl, pH 8.0, 20 mM NaCl, 1 mM event ultimately leads to transmission of action potentials to the brain and EDTA buffered solution. the subsequent perception of smell. -
Identification of Candidate Biomarkers and Pathways Associated with Type 1 Diabetes Mellitus Using Bioinformatics Analysis
bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Type 1 diabetes mellitus (T1DM) is a metabolic disorder for which the underlying molecular mechanisms remain largely unclear. This investigation aimed to elucidate essential candidate genes and pathways in T1DM by integrated bioinformatics analysis. In this study, differentially expressed genes (DEGs) were analyzed using DESeq2 of R package from GSE162689 of the Gene Expression Omnibus (GEO). Gene ontology (GO) enrichment analysis, REACTOME pathway enrichment analysis, and construction and analysis of protein-protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network, and validation of hub genes were then performed. A total of 952 DEGs (477 up regulated and 475 down regulated genes) were identified in T1DM. GO and REACTOME enrichment result results showed that DEGs mainly enriched in multicellular organism development, detection of stimulus, diseases of signal transduction by growth factor receptors and second messengers, and olfactory signaling pathway. -
WO 2019/068007 Al Figure 2
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/068007 Al 04 April 2019 (04.04.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors; and C12N 15/10 (2006.01) C07K 16/28 (2006.01) (71) Applicants: GROSS, Gideon [EVIL]; IE-1-5 Address C12N 5/10 (2006.0 1) C12Q 1/6809 (20 18.0 1) M.P. Korazim, 1292200 Moshav Almagor (IL). GIBSON, C07K 14/705 (2006.01) A61P 35/00 (2006.01) Will [US/US]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., C07K 14/725 (2006.01) P.O. Box 4044, 7403635 Ness Ziona (TL). DAHARY, Dvir [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (21) International Application Number: Box 4044, 7403635 Ness Ziona (IL). BEIMAN, Merav PCT/US2018/053583 [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (22) International Filing Date: Box 4044, 7403635 Ness Ziona (E.). 28 September 2018 (28.09.2018) (74) Agent: MACDOUGALL, Christina, A. et al; Morgan, (25) Filing Language: English Lewis & Bockius LLP, One Market, Spear Tower, SanFran- cisco, CA 94105 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 62/564,454 28 September 2017 (28.09.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/649,429 28 March 2018 (28.03.2018) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (71) Applicant: IMMP ACT-BIO LTD. -
Functional Variability in the Human Odorant Receptor Repertoire
ART ic LE s The missense of smell: functional variability in the human odorant receptor repertoire Joel D Mainland1–3, Andreas Keller4, Yun R Li2,6, Ting Zhou2, Casey Trimmer1, Lindsey L Snyder1, Andrew H Moberly1,3, Kaylin A Adipietro2, Wen Ling L Liu2, Hanyi Zhuang2,6, Senmiao Zhan2, Somin S Lee2,6, Abigail Lin2 & Hiroaki Matsunami2,5 Humans have ~400 intact odorant receptors, but each individual has a unique set of genetic variations that lead to variation in olfactory perception. We used a heterologous assay to determine how often genetic polymorphisms in odorant receptors alter receptor function. We identified agonists for 18 odorant receptors and found that 63% of the odorant receptors we examined had polymorphisms that altered in vitro function. On average, two individuals have functional differences at over 30% of their odorant receptor alleles. To show that these in vitro results are relevant to olfactory perception, we verified that variations in OR10G4 genotype explain over 15% of the observed variation in perceived intensity and over 10% of the observed variation in perceived valence for the high-affinity in vitro agonist guaiacol but do not explain phenotype variation for the lower-affinity agonists vanillin and ethyl vanillin. The human genome contains ~800 odorant receptor genes that have RESULTS been shown to exhibit high genetic variability1–3. In addition, humans High-throughput screening of human odorant receptors exhibit considerable variation in the perception of odorants4,5, and To identify agonists for a variety of odorant receptors, we cloned a variation in an odorant receptor predicts perception in four cases: library of 511 human odorant receptor genes for a high-throughput loss of function in OR11H7P, OR2J3, OR5A1 and OR7D4 leads to heterologous screen. -
Human Olfactory Receptors
Human Olfactory Receptors: A journey from cell engineering for efficient in vitro functional assays to effective antagonists in human sensory assay Huysseune Sandra, Philippeau Magali, Moreau Cédric, Veithen Alex, Chatelain Pierre, Quesnel Yannick. ChemCom S.A., Route de Lennik 802, 1070 Anderlecht, Belgium. Cell lines Introduction: ChemCom's Entry ORs Literature data HEK293T HANA3 proprietary Many odorant compounds are perceived as unpleasant. They can be present in different contexts such as body-, home-, factory-, material-, or fabric-emitted 1 OR56A1 Adipietro et al., 2012 odors, so that humans are daily exposed to this olfactory pollution. In addition, odorant compounds can also taint food or beverages. Malodor and off-note 2 OR10J5 Saito et al., 2009 counteraction is a daily challenge for many different industries. 3 ORX116 - The first step of the odor perception corresponds to the interaction of olfactory receptors (ORs) with odorant molecules. Therefore, a selective inhibition of the 4 ORX069 - ORs by weakly odorant or odorless antagonists represents an innovative solution to malodor issues. The identification of such odor blockers requires an 5 OR10H5 - efficient technological platform to first fish out the receptors that interact with a malodor of interest and second, to screen libraries of potential antagonists of 6 OR8B3 Mainland et al., 2013 7 OR6P1 Mainland et al., 2013 these ORs. 8 ORX074B - 9 ORX126 - Materials and Methods: 10 ORX189 - 11 ORX081 - In vitro functional assay 12 ORX213 - Dilution-response analysis were performed in HEK293T, HANA3 and HEK293T-hRTP1S/hRTP2 cells using the CRE-luciferase reporter assay system. Briefly, each 13 OR1D2 Spehr et al., 2003 cell plated one day before was transfected with deorphanized ORs (identified at Chemcom S.A.) or empty vector plasmids using TransIT®-LT1 (Mirus) 14 OR7C1 Mainland et al., 2013 according to the manufacturer’s protocol. -
Personal Receptor Repertoires: Olfaction As a Model
Olender et al. BMC Genomics 2012, 13:414 http://www.biomedcentral.com/1471-2164/13/414 RESEARCH ARTICLE Open Access Personal receptor repertoires: olfaction as a model Tsviya Olender1*, Sebastian M Waszak2, Maya Viavant1, Miriam Khen1, Edna Ben-Asher1, Alejandro Reyes3, Noam Nativ1, Charles J Wysocki4, Dongliang Ge5 and Doron Lancet1* Abstract Background: Information on nucleotide diversity along completely sequenced human genomes has increased tremendously over the last few years. This makes it possible to reassess the diversity status of distinct receptor proteins in different human individuals. To this end, we focused on the complete inventory of human olfactory receptor coding regions as a model for personal receptor repertoires. Results: By performing data-mining from public and private sources we scored genetic variations in 413 intact OR loci, for which one or more individuals had an intact open reading frame. Using 1000 Genomes Project haplotypes, we identified a total of 4069 full-length polypeptide variants encoded by these OR loci, average of ~10 per locus, constituting a lower limit for the effective human OR repertoire. Each individual is found to harbor as many as 600 OR allelic variants, ~50% higher than the locus count. Because OR neuronal expression is allelically excluded, this has direct effect on smell perception diversity of the species. We further identified 244 OR segregating pseudogenes (SPGs), loci showing both intact and pseudogene forms in the population, twenty-six of which are annotatively “resurrected” from a pseudogene status in the reference genome. Using a custom SNP microarray we validated 150 SPGs in a cohort of 468 individuals, with every individual genome averaging 36 disrupted sequence variations, 15 in homozygote form. -
The Hypothalamus As a Hub for SARS-Cov-2 Brain Infection and Pathogenesis
bioRxiv preprint doi: https://doi.org/10.1101/2020.06.08.139329; this version posted June 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis Sreekala Nampoothiri1,2#, Florent Sauve1,2#, Gaëtan Ternier1,2ƒ, Daniela Fernandois1,2 ƒ, Caio Coelho1,2, Monica ImBernon1,2, Eleonora Deligia1,2, Romain PerBet1, Vincent Florent1,2,3, Marc Baroncini1,2, Florence Pasquier1,4, François Trottein5, Claude-Alain Maurage1,2, Virginie Mattot1,2‡, Paolo GiacoBini1,2‡, S. Rasika1,2‡*, Vincent Prevot1,2‡* 1 Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, DistAlz, UMR-S 1172, Lille, France 2 LaBoratorY of Development and PlasticitY of the Neuroendocrine Brain, FHU 1000 daYs for health, EGID, School of Medicine, Lille, France 3 Nutrition, Arras General Hospital, Arras, France 4 Centre mémoire ressources et recherche, CHU Lille, LiCEND, Lille, France 5 Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and ImmunitY of Lille (CIIL), Lille, France. # and ƒ These authors contriButed equallY to this work. ‡ These authors directed this work *Correspondence to: [email protected] and [email protected] Short title: Covid-19: the hypothalamic hypothesis 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.08.139329; this version posted June 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. -
DNA Copy Number Aberrations Associated with Aneuploidy and Chromosomal Instability in Breast Cancers
875-883.qxd 25/8/2010 10:49 Ì ™ÂÏ›‰·875 ONCOLOGY REPORTS 24: 875-883, 2010 875 DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers SHIGETO KAWAUCHI1, TOMOKO FURUYA1, KENZO IKEMOTO1, MOTONAO NAKAO1, SHIGERU YAMAMOTO2, MASAAKI OKA2 and KOHSUKE SASAKI1 Departments of 1Pathology and 2Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan Received May 8, 2010; Accepted June 21, 2010 DOI: 10.3892/or_00000933 Abstract. Biological characteristics of a tumor are primarily somal material (1,2). Aneuploidy, an alteration in the number affected by its genomic alterations. It is thus important to of chromosomes or nuclear DNA content, is a common trait ascertain whether there are genomic changes linked with of tumor cells, and it drives tumor progression (3). With DNA ploidy and/or chromosomal instability (CIN). In the tumor progression, aneuploidy successively confers a more present study, using fresh-frozen samples of 46 invasive aggressive character to tumor cells (4). Thus, aneuploidy breast cancers, laser scanning cytometry, array-based com- has been used as a prognostic marker of various kinds of parative genomic hybridization, and chromosome fluore- cancers including breast cancer (5-7). scence in situ hybridization were performed to assess DNA Genomic instability is also recognized as inherent chara- ploidy, DNA copy number aberrations (DCNAs), and CIN cteristics of cancer cells. The underlying mechanisms of status. Both ploidy and CIN status were examined in 36 genomic instability are different among tumors. Genomic tumors, resulting in 23 aneuploid/CIN+ tumors, 1 aneuploid/ instability is roughly divided into microsatellite instability CIN-, 2 diploid/CIN+, and 10 diploid/CIN- tumors. -
Dynamic Functional Evolution of an Odorant Receptor for Sex-Steroid-Derived Odors in Primates
Dynamic functional evolution of an odorant receptor for sex-steroid-derived odors in primates Hanyi Zhuanga,b,1, Ming-Shan Chiena, and Hiroaki Matsunamia,c,1 Departments of aMolecular Genetics and Microbiology and cNeurobiology, Duke University Medical Center, Durham, NC 27710; and bDepartment of Pathophysiology, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China Edited by Masatoshi Nei, Pennsylvania State University, University Park, PA, and approved October 20, 2009 (received for review August 27, 2008) Odorant receptors are among the fastest evolving genes in ani- responded to these chemicals and appeared to be more sensitive mals. However, little is known about the functional changes of than the human S84N variant (9). individual odorant receptors during evolution. We have recently Positive Darwinian selection (positive selection) is a phenom- demonstrated a link between the in vitro function of a human enon whereby natural selection favors changes. As olfaction is odorant receptor, OR7D4, and in vivo olfactory perception of 2 essential for detecting food sources, avoiding toxic compounds steroidal ligands—androstenone and androstadienone—chemi- or predators, and evaluating mates, positive selection on an OR cals that are shown to affect physiological responses in humans. In gene, if any, can be important in modulating species-specific this study, we analyzed the in vitro function of OR7D4 in primate behaviors by changing sequences of the ORs, thereby modifying evolution. Orthologs of OR7D4 were cloned from different primate odor specificity and sensitivity. It is, however, possible that species. Ancestral reconstruction allowed us to reconstitute addi- olfaction is of diminishing importance to primates and therefore tional putative OR7D4 orthologs in hypothetical ancestral species. -
Amino Acid Sequences Directed Against Cxcr4 And
(19) TZZ ¥¥_T (11) EP 2 285 833 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07K 16/28 (2006.01) A61K 39/395 (2006.01) 17.12.2014 Bulletin 2014/51 A61P 31/18 (2006.01) A61P 35/00 (2006.01) (21) Application number: 09745851.7 (86) International application number: PCT/EP2009/056026 (22) Date of filing: 18.05.2009 (87) International publication number: WO 2009/138519 (19.11.2009 Gazette 2009/47) (54) AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME GEGEN CXCR4 UND ANDERE GPCR GERICHTETE AMINOSÄURESEQUENZEN SOWIE VERBINDUNGEN DAMIT SÉQUENCES D’ACIDES AMINÉS DIRIGÉES CONTRE CXCR4 ET AUTRES GPCR ET COMPOSÉS RENFERMANT CES DERNIÈRES (84) Designated Contracting States: (74) Representative: Hoffmann Eitle AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Patent- und Rechtsanwälte PartmbB HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL Arabellastraße 30 PT RO SE SI SK TR 81925 München (DE) (30) Priority: 16.05.2008 US 53847 P (56) References cited: 02.10.2008 US 102142 P EP-A- 1 316 801 WO-A-99/50461 WO-A-03/050531 WO-A-03/066830 (43) Date of publication of application: WO-A-2006/089141 WO-A-2007/051063 23.02.2011 Bulletin 2011/08 • VADAY GAYLE G ET AL: "CXCR4 and CXCL12 (73) Proprietor: Ablynx N.V. (SDF-1) in prostate cancer: inhibitory effects of 9052 Ghent-Zwijnaarde (BE) human single chain Fv antibodies" CLINICAL CANCER RESEARCH, THE AMERICAN (72) Inventors: ASSOCIATION FOR CANCER RESEARCH, US, • BLANCHETOT, Christophe vol.10, no. -
Supplementary Data
SUPPLEMENTARY METHODS 1) Characterisation of OCCC cell line gene expression profiles using Prediction Analysis for Microarrays (PAM) The ovarian cancer dataset from Hendrix et al (25) was used to predict the phenotypes of the cell lines used in this study. Hendrix et al (25) analysed a series of 103 ovarian samples using the Affymetrix U133A array platform (GEO: GSE6008). This dataset comprises clear cell (n=8), endometrioid (n=37), mucinous (n=13) and serous epithelial (n=41) primary ovarian carcinomas and samples from 4 normal ovaries. To build the predictor, the Prediction Analysis of Microarrays (PAM) package in R environment was employed (http://rss.acs.unt.edu/Rdoc/library/pamr/html/00Index.html). When more than one probe described the expression of a given gene, we used the probe with the highest median absolute deviation across the samples. The dataset from Hendrix et al. (25) and the dataset of OCCC cell lines described in this manuscript were then overlaid on the basis of 11536 common unique HGNC gene symbols. Only the 99 primary ovarian cancers samples and the four normal ovary samples were used to build the predictor. Following leave one out cross-validation, a predictor based upon 126 genes was able to identify correctly the four distinct phenotypes of primary ovarian tumour samples with a misclassification rate of 18.3%. This predictor was subsequently applied to the expression data from the 12 OCCC cell lines to determine the likeliest phenotype of the OCCC cell lines compared to primary ovarian cancers. Posterior probabilities were estimated for each cell line in comparison to the following phenotypes: clear cell, endometrioid, mucinous and serous epithelial.